Please login to the form below

Not currently logged in
Email:
Password:

orphan diseases

This page shows the latest orphan diseases news and features for those working in and with pharma, biotech and healthcare.

China approves Ironwood Pharma’s IBS treatment

China approves Ironwood Pharma’s IBS treatment

Cyclerion will focus on five promising candidates in the soluble guanylate cyclase (sGC) class, targeting serious and orphan diseases.

Latest news

  • PMEA 2018: celebrating excellence in improving patient outcomes PMEA 2018: celebrating excellence in improving patient outcomes

    AbbVie also took home two other awards, Excellence in Healthcare Professional Education Support Programmes (with support from Sciterion) and Excellence in Rare Diseases and Orphan Drugs (with support from Lucid). ... Meanwhile, for AbbVie’s and

  • Orphan drugs from Biogen and Amicus win UK Prix Galien Orphan drugs from Biogen and Amicus win UK Prix Galien

    There was a much warmer welcome at the awards, hosted by ValueBase, for the pharma and biotech companies with products on the shortlist, which was dominated by orphan medicines. ... All bar one of the finalists were medicines for orphan conditions, and

  • Malthus’ orphans Malthus’ orphans

    Shire. The attractiveness of rare diseases, orphan drugs and other ‘ultra niche’ strategies is their high relative profitability; governments tolerate high cost per patient because the patients are few and often ... By and large, rare diseases and

  • The year of the blockbuster The year of the blockbuster

    The diseases targeted by the report’s projected market entrants include type 2 diabetes, endometriosis, childhood epilepsy, haemophilia, HIV, migraine, opioid addiction and shingles. ... Five of the 12 drugs  we identified are first-in-class  and

  • Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report

    That assertion ties in with its new report on worldwide prescription drug sales, which says that drugs for orphan diseases will outperform the overall pharma market, almost doubling to reach a ... That will also be a factor for orphan drugs, with recent

More from news
Approximately 3 fully matching, plus 116 partially matching documents found.

Latest Intelligence

  • Europe vs the US: New drug product approvals Europe vs the US: New drug product approvals

    During 2016, special approval procedures like conditional and accelerated approval pathways were issued for seven of the new approvals in the EU, the majority in oncology and for orphan diseases. ... We expect the strong overall trend for more orphan

  • Rare diseases: meeting the challenge Rare diseases: meeting the challenge

    However, fewer than 1, 000 diseases ‘benefit from even minimal amounts of scientific knowledge’, the EMA says. ... Numbers game. The number of orphan drugs actually being approved in Europe is hard to quantify.

  • Deal Watch February 2017 Deal Watch February 2017

    IMMU-132 has FDA Breakthrough Therapy designation for the treatment of patients with TNBC who have failed prior therapies for metastatic disease and also has Fast Track status and orphan designation ... The amendment gives Vifor the rights to

  • A rare talent A rare talent

    Shire’s Sebastian Stachowiak on dealing with change and working for a fit-for-purpose orphan drug environment. ... A rare challenge. That knowledge is currently focused on bringing new treatments to market for rare diseases and working to ensure the

  • Mastering the rare disease challenge Mastering the rare disease challenge

    Identifying expertise and customising communication in orphan drug marketing. Orphan drugs are few and far between. ... Clinicians often have little or no concept of how diseases like sarcoidosis or systemic sclerosis present themselves and have

More from intelligence
Approximately 0 fully matching, plus 28 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Top Pharma News

TopPharmaNews.com is a global pharma magazine dedicated to delivering fresh news to society. The team at the TopPharmaNews.com cater non-biased,...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics